Polyelectrolyte complexes of hTERT siRNA and polyethyleneimine: Effect of degree of PEG grafting on biological and cellular activity

References

• Akbarzadeh A, Mikaeili H, Zarghami N, Mohammad R, Barkhordari A, Davaran S. 2012. Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 7:511–536.
   PubMed Web of Science ®Google Scholar
• Araujo R, Santos A, Pinto F, Gontijo N, Lehane M, Pereira M. 2006. RNA interference of the salivary gland nitrophorin 2 in the triatomine bug Rhodnius prolixus (Hemiptera: Reduviidae) by dsRNA ingestion or injection. Insect Biochem Mol Biol. 36:683–693.
   PubMed Web of Science ®Google Scholar
• Beyerle A, Merkel O, Stoeger T, Kissel T. 2010. PEGylation affects cytotoxicity and cell-compatibility of poly (ethylene imine) for lung application: structure–function relationships. Toxicol Appl Pharmacol. 242:146–154.
   PubMed Web of Science ®Google Scholar
• Blackburn EH. 1994. Telomeres: no end in sight. Cell. 77:621–623.
   PubMed Web of Science ®Google Scholar
• Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R. 2003. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet. 34:263–264.
   PubMed Web of Science ®Google Scholar
• Bumcrot D, Manoharan M, Koteliansky V, Sah DW. 2006. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol. 2:711–719.
   PubMed Web of Science ®Google Scholar
• Choosakoonkriang S, Lobo BA, Koe GS, Koe JG, Middaugh CR. 2003. Biophysical characterization of PEI/DNA complexes. J Pharm Sci. 92:1710–1722.
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494–498.
   PubMed Web of Science ®Google Scholar
• Grayson ACR, Doody AM, Putnam D. 2006. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res. 23:1868–1876.
   PubMed Web of Science ®Google Scholar
• Grimm D, Kay MA. 2007. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? J Clin Invest. 117:3633–3641.
   PubMed Web of Science ®Google Scholar
• Heale BS, Soifer HS, Bowers C, Rossi JJ. 2005. siRNA target site secondary structure predictions using local stable substructures. Nucleic Acids Res. 33:e30.
   PubMed Web of Science ®Google Scholar
• Hisatomi H, Ohyashiki K, Ohyashiki JH, Nagao K, Kanamaru T, Hirata H, et al. 2003. Expression profile of a γ-deletion variant of the human telomerase reverse transcriptase gene. Neoplasia. 5:193–197.
   PubMed Web of Science ®Google Scholar
• Kichler A, Chillon M, Leborgne C, Danos O, Frisch B. 2002. Intranasal gene delivery with a polyethylenimine–PEG conjugate. J Control Release. 81:379–388.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick K, Clark G, Ghilchick M, Newbold R, Mokbel K. 2003. hTERT mRNA expression correlates with telomerase activity in human breast cancer. Eur J Surg Oncol. 29:321–326.
   PubMed Web of Science ®Google Scholar
• Liang Y, Liu Z, Shuai X, Wang W, Liu J, Bi W, et al. 2012. Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration. Biochem Biophys Res Commun. 421:690–695.
   PubMed Web of Science ®Google Scholar
• Mao S, Neu M, Germershaus O, Merkel O, Sitterberg J, Bakowsky U, Kissel T. 2006. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly (ethylene imine)-graft-poly (ethylene glycol) block copolymer/SiRNA polyplexes. Bioconjugate Chem. 17:1209–1218.
   PubMed Web of Science ®Google Scholar
• Merkel OM, Librizzi D, Pfestroff A, Schurrat T, Buyens K, Sanders NN, et al. 2009. Stability of siRNA polyplexes from poly (ethylenimine) and poly (ethylenimine)-g-poly (ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging. J Control Release. 138:148–159.
   PubMed Web of Science ®Google Scholar
• Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, et al. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. cell. 90:785–795.
   PubMed Web of Science ®Google Scholar
• Moreira J, Santos A, Moura V, Pedroso de Lima M, Simoes S. 2008. Non-viral lipid-based nanoparticles for targeted cancer systemic gene silencing. J Nanosci Nanotechnol. 8:2187–2204.
   PubMed Web of Science ®Google Scholar
• Morin GB. 1989. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 59: 521–529.
   PubMed Web of Science ®Google Scholar
• Oskuee RK, Philipp A, Dehshahri A, Wagner E, Ramezani M. 2010. The impact of carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA delivery. J Gene Med. 12:729–738.
   PubMed Web of Science ®Google Scholar
• Petersen H, Fechner PM, Martin AL, Kunath K, Stolnik S, Roberts CJ, et al. 2002. Polyethylenimine-graft-poly (ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem. 13:845–854.
   PubMed Web of Science ®Google Scholar
• Rahmati-Yamchi M, Zarghami N, Rahbani M, Montazeri A. 2011. Plasma leptin, hTERT gene expression, and anthropometric measures in obese and non-obese women with breast cancer. Breast cancer: Basic and Clinical Research. 5:27–35.
   PubMedGoogle Scholar
• Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. 2004. Rational siRNA design for RNA interference. Nat Biotechnol. 22:326–330.
   PubMed Web of Science ®Google Scholar
• Saengkrit N, Sanitrum P, Woramongkolchai N, Saesoo S, Pimpha N, Chaleawlert-umpon S, et al. 2012. The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/ E7 oncogenes in human cervical cells. Carbohydr Polym. 90: 1323–1329.
   PubMed Web of Science ®Google Scholar
• Samal SK, Dash M, Van Vlierberghe S, Kaplan DL, Chiellini E, Van Blitterswijk C, et al. 2012. Cationic polymers and their therapeutic potential. Chem Soc Rev. 41:7147–7194.
   PubMed Web of Science ®Google Scholar
• Shay JW, Zou Y, Hiyama E, Wright WE. 2001. Telomerase and cancer. Hum Mol Gen. 10:677–685.
   PubMed Web of Science ®Google Scholar
• Takasaki S, Kotani S, Konagaya A. 2004. An effective method for selecting siRNA target sequences in mammalian cells. Cell Cycle. 3:788–793.
   Web of Science ®Google Scholar
• Tuschl T, Zamore PD, Lehmann R, Bartel DP, Sharp PA. 1999. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13:3191–3197.
   PubMed Web of Science ®Google Scholar
• Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, et al. 2004. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 32:936–948.
   PubMed Web of Science ®Google Scholar
• Weber ND, Merkel OM, Kissel T, Muñoz-Fernández MÁ. 2012. PEGylated poly (ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro. J Control Release. 157:55–63.
   PubMed Web of Science ®Google Scholar
• Woods NB, Bottero V, Schmidt M, von Kalle C, Verma IM. 2006. Gene therapy: therapeutic gene causing lymphoma. Nature. 440:1123–1123.
   PubMed Web of Science ®Google Scholar
• Xu F, Yang W. 2011. Polymer vectors via controlled/living radical polymerization for gene delivery. Prog Polym Sci. 36:1099–1131.
   Web of Science ®Google Scholar
• Yamagishi M, Ishida T, Miyake A, Cooper DA, Kelleher AD, Suzuki K, Watanabe T. 2009. Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription. Microbes Infect. 11:500–508.
   PubMed Web of Science ®Google Scholar
• Zamore PD, Tuschl T, Sharp PA, Bartel DP. 2000. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 101:25–33.
   PubMed Web of Science ®Google Scholar
• Zhang PH, Zou L, Tu ZG. 2006. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity. J Surg Res. 131:143–149.
   PubMed Web of Science ®Google Scholar
• Zhou J, Shum KT, Burnett JC, Rossi JJ. 2013. Nanoparticle-based delivery of RNAi therapeutics: progress and challenges. Pharmaceuticals. 6:85–107.
   Google Scholar